REGN News

$REGN Stock Loss: Regeneron May Have Misrepresented its Trial Results to Investors - Contact BFA Law About The Pending Securities Fraud Class Action

REGN CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?

Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Contact Levi & Korsinsky Before September 14, 2026 to Join Class Action

Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)

Pomerantz LLP Advises Shareholders of Class Action Filing Against Regeneron Pharmaceuticals, Inc. – REGN

REGN Deadline Reminder: Regeneron Securities Fraud Class Action Over Alleged Misrepresentations is Ongoing - September 14 Court Deadline For Investors is Approaching

REGN ALERT: Securities Fraud Class Action Launched Against Regeneron Pharmaceuticals, Inc. - September 14, 2026 Deadline

Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSS

REGN DEADLINE: The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline

Investor Alert: Deadline Approaching to Join Regeneron Pharmaceuticals, Inc. (REGN) Class Action - Contact Levi & Korsinsky